Ivey Business School (Canada)
-
Pfizer and the Challenges of the Pharmaceutical Industry (A)
Renate Kratochvil; Phillip C. NellCase IVEY-9B19M076-EStrategyIn 2018, President of the United States, Donald Trump, criticized the company Pfizer Inc. (Pfizer) for increasing drug prices—which had been a strategic move by Pfizer in response to industry-wide challenges. This announcement highlighted the complex dynaStarting at €8.20
-
PharmaCo
Michael Parent; Greg Murray; Sundeep SandhuCase IVEY-9B20M053-EStrategyPharmaCo was a large, multinational, integrated pharmaceutical company. Its board of directors was meeting to discuss a possible friendly merger with a complementary competitor and to review a quarterly cybersecurity report. However, before either of these discussions could begin, PharmaCo’s chief financial officer interrupted with news that the company’s customer database had been encrypted by hackers in a ransomware attack and a ransom of $25,0...Starting at €8.20
-
Pfizer and the Challenges of the Pharmaceutical Industry (B)
Renate Kratochvil; Phillip C. NellCase IVEY-9B19M077-EStrategyCase B complements Case A, describing pharmaceutical companies’ strategic responses—such as mega-mergers and acquisitions and specialization—to industry-wide global challenges and highlights strategic decisions by Pfizer’s chief executive officers betweenStarting at €5.74
-
PharmaCo (Spanish version)
Michael Parent; Greg Murray; Sundeep SandhuCase IVEY-W28532StrategyPharmaCo was a large, multinational, integrated pharmaceutical company. Its board of directors was meeting to discuss a possible friendly merger with a complementary competitor and to review a quarterly cybersecurity report. However, before either of these discussions could begin, PharmaCo’s chief financial officer interrupted with news that the company’s customer database had been encrypted by hackers in a ransomware attack and a ransom of $25,0...Starting at €8.20